In our study, PTP1B‐IN‐1 administration effectively suppressed the elevated Iba‐1, GFAP, TNF‐α, IL‐6, and IL‐1β in SNI‐induced neuropathic pain rats. The gene discussed is GFAP; the disease is neuropathic pain.